← all drugs
Propranolol Hydrochloride Injection
in shortage · Cardiovascular · Snapshot: 2026-10-09
Day 1,074
of this shortage, counting from the FDA's first posting on 10/31/2023
- Manufacturers listed
- Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc.
- Reported reason(s)
- Shortage of an active ingredient
- Machine-readable
- JSON for this drug
Presentations (2)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-604-01) | Fresenius Kabi USA, LLC | Available | 09/15/2026 |
| Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 0143-9872-10) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 09/18/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.